Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Income from Continuing Operations (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Income from Continuing Operations readings, the most recent being 6745000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 989.66% to 6745000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 56697000.0, a 1.12% decrease, with the full-year FY2025 number at 56697000.0, down 1.12% from a year prior.
  • Income from Continuing Operations hit 6745000.0 in Q4 2025 for Treace Medical Concepts, up from 16380000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 619000.0 in Q4 2024 to a low of 21318000.0 in Q2 2024.
  • Median Income from Continuing Operations over the past 5 years was 12227000.0 (2022), compared with a mean of 11055850.0.
  • Biggest five-year swings in Income from Continuing Operations: soared 90.29% in 2024 and later plummeted 989.66% in 2025.
  • Treace Medical Concepts' Income from Continuing Operations stood at 6620000.0 in 2021, then surged by 38.75% to 4055000.0 in 2022, then tumbled by 57.26% to 6377000.0 in 2023, then soared by 90.29% to 619000.0 in 2024, then plummeted by 989.66% to 6745000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 6745000.0 (Q4 2025), 16380000.0 (Q3 2025), and 17520000.0 (Q2 2025) per Business Quant data.